227 related articles for article (PubMed ID: 3755053)
1. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
Hill RP; Gulyas S; Whitmore GF
Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
[TBL] [Abstract][Full Text] [Related]
2. The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor.
Chaplin DJ; Durand RE; Stratford IJ; Jenkins TC
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1091-5. PubMed ID: 3755714
[TBL] [Abstract][Full Text] [Related]
3. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
[TBL] [Abstract][Full Text] [Related]
4. Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.
Stratford IJ; Adams GE; Godden J; Howells N
Int J Radiat Biol; 1989 Mar; 55(3):411-22. PubMed ID: 2564037
[TBL] [Abstract][Full Text] [Related]
5. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
[TBL] [Abstract][Full Text] [Related]
6. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
[TBL] [Abstract][Full Text] [Related]
7. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of RSU-1069 for KHT cells treated in vivo or in vitro: evidence for a diffusible toxic product.
Hill RP; Gulyas S; Whitmore GF
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1111-4. PubMed ID: 2703391
[TBL] [Abstract][Full Text] [Related]
9. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
Siemann DW
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
[TBL] [Abstract][Full Text] [Related]
10. Induction of mutations in V79-4 mammalian cells under hypoxic and aerobic conditions by the cytotoxic 2-nitroimidazole-aziridines, RSU-1069 and RSU-1131. The influence of cellular glutathione.
Sapora O; Paone A; Maggi A; Jenner TJ; O'Neill P
Biochem Pharmacol; 1992 Oct; 44(7):1341-7. PubMed ID: 1417957
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and cytotoxicity of RSU-1069 in subcutaneous 9L tumours under oxic and hypoxic conditions.
Wong KH; Koch CJ; Wallen CA; Wheeler KT
Br J Cancer; 1991 Apr; 63(4):484-8. PubMed ID: 2021530
[TBL] [Abstract][Full Text] [Related]
12. Studies on the toxicity of RSU-1069.
Whitmore GF; Gulyas S
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1219-22. PubMed ID: 3755716
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
Binger M; Workman P
Cancer Chemother Pharmacol; 1991; 29(1):37-47. PubMed ID: 1742848
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic transforming potential of nitroimidazole radiosensitizers.
Hall EJ; Hei TK
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1231-4. PubMed ID: 2523882
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Siemann DW; Maddison K; Wolf K
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
[TBL] [Abstract][Full Text] [Related]
16. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
Austen KR; Jenner TJ; O'Neill P; Fielden EM
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
[TBL] [Abstract][Full Text] [Related]
17. Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice.
Cole S; Stratford IJ; Bowler J; Nolan J; Wright EG; Lorimore SA; Adams GE
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):387-95. PubMed ID: 2061115
[TBL] [Abstract][Full Text] [Related]
18. Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizer. Role of binding of both unreduced and radiation-reduced forms to DNA, in vitro.
Silver AR; O'Neill P; Jenkins TC
Biochem Pharmacol; 1985 Oct; 34(19):3537-42. PubMed ID: 3902026
[TBL] [Abstract][Full Text] [Related]
19. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
Holden SA; Teicher BA; Herman TS
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
[TBL] [Abstract][Full Text] [Related]
20. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
